Pentagalloyl Glucose and Its Functional Role in Vascular Health: Biomechanics and Drug-Delivery Characteristics

被引:38
作者
Patnaik, Sourav S. [1 ]
Simionescu, Dan T. [2 ]
Goergen, Craig J. [3 ]
Hoyt, Kenneth [4 ,5 ]
Sirsi, Shashank [4 ,5 ]
Finol, Ender A. [1 ]
机构
[1] Univ Texas San Antonio, Vasc Biomech & Biofluids Lab, Dept Mech Engn, One UTSA Circle, San Antonio, TX 78249 USA
[2] Clemson Univ, Dept Bioengn, Clemson, SC USA
[3] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA
[4] Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA
[5] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX USA
关键词
Pentagalloyl glucose; Abdominal aortic aneurysms; Elastin; Collagen; Drug delivery; BETA-D-GLUCOSE; ABDOMINAL AORTIC-ANEURYSM; ULTRASOUND CONTRAST AGENTS; DOWN-REGULATION; TANNIC-ACID; GROWTH-RATE; IN-VITRO; POLYMERIC NANOPARTICLES; ELASTIN STABILIZATION; SALIVARY PROTEINS;
D O I
10.1007/s10439-018-02145-5
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Pentagalloyl glucose (PGG) is an elastin-stabilizing polyphenolic compound that has significant biomedical benefits, such as being a free radical sink, an anti-inflammatory agent, anti-diabetic agent, enzymatic resistant properties, etc. This review article focuses on the important benefits of PGG on vascular health, including its role in tissue mechanics, the different modes of pharmacological administration (e.g., oral, intravenous and endovascular route, intraperitoneal route, subcutaneous route, and nanoparticle based delivery and microbubble-based delivery), and its potential therapeutic role in vascular diseases such as abdominal aortic aneurysms (AAA). In particular, the use of PGG for AAA suppression and prevention has been demonstrated to be effective only in the calcium chloride rat AAA model. Therefore, in this critical review we address the challenges that lie ahead for the clinical translation of PGG as an AAA growth suppressor.
引用
收藏
页码:39 / 59
页数:21
相关论文
共 195 条
[1]   Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity [J].
Abdel-Mageed, Wael M. ;
Bayoumi, Soad A. H. ;
Chen, Caixia ;
Vavricka, Christopher J. ;
Li, Li ;
Malik, Ajamaluddin ;
Dai, Huanqin ;
Song, Fuhang ;
Wang, Luoqiang ;
Zhang, Jingyu ;
Gao, George F. ;
Lv, Yali ;
Liu, Lihong ;
Liu, Xueting ;
Sayed, Hanaa M. ;
Zhang, Lixin .
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (07) :2236-2243
[2]   Study of antimutagenic and antioxidant activities of Gallic acid and 1,2,3,4,6-pentagalloylglucose from Pistacia lentiscus -: Confirmation by microarray expression profiling [J].
Abdelwahed, Afef ;
Bouhlel, Ines ;
Skandrani, Ines ;
Valenti, Kita ;
Kadri, Malika ;
Guiraud, Pascal ;
Steiman, Regine ;
Mariotte, Anne-Marie ;
Ghedira, Kamel ;
Laporte, Francois ;
Dijoux-Franca, Marie-Genevieve ;
Chekir-Ghedira, Leila .
CHEMICO-BIOLOGICAL INTERACTIONS, 2007, 165 (01) :1-13
[3]   Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content [J].
Abdul-Hussien, Hazem ;
Hanemaaijer, Roeland ;
Verheijen, Jan H. ;
van Bockel, J. Hajo ;
Geelkerken, Robert H. ;
Lindeman, Jan H. N. .
JOURNAL OF VASCULAR SURGERY, 2009, 49 (03) :741-749
[4]   Cellular content and permeability of intraluminal thrombus in abdominal aortic aneurysm [J].
Adolph, R ;
Vorp, DA ;
Steed, DL ;
Webster, MW ;
Kameneva, MV ;
Watkins, SC .
JOURNAL OF VASCULAR SURGERY, 1997, 25 (05) :916-926
[5]   Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum [J].
Alkilani, Ahlam Zaid ;
McCrudden, Maeliosa T. C. ;
Donnelly, Ryan F. .
PHARMACEUTICS, 2015, 7 (04) :438-470
[6]  
Allaire E, 2010, CYCLOSPORINE PATIENT
[7]   Update on the safety and efficacy of commercial ultrasound contrast agents in cardiac applications [J].
Appis A.W. ;
Tracy M.J. ;
Feinstein S.B. .
Echo Research & Practice, 2015, 2 (2) :R55-R62
[8]  
Bahadar Haji, 2016, Iranian Biomedical Journal, V20, P1, DOI 10.7508/ibj.2016.01.001
[9]   Drug Delivery Systems for Intraperitoneal Therapy [J].
Bajaj, Gaurav ;
Yeo, Yoon .
PHARMACEUTICAL RESEARCH, 2010, 27 (05) :735-738
[10]   Doxil® - The first FDA-approved nano-drug: Lessons learned [J].
Barenholz, Yechezkel .
JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :117-134